The MARS platform combines magnets and machinery.
Levita Magnetics announced that it has received FDA clearance for its MARS platform.
The system is a surgical platform that uses magnets and machines to reduce the number of incisions while providing surgeons with control. The minimally invasive platform is designed for use with abdominal surgery.
In a press release, Levita Magnetics CEO Dr. Alberto Rodriguez-Navarro said, “Today marks a significant milestone in Levita's mission to provide more patients access to state-of-the-art surgical technology. MARS is poised to revolutionize surgical options for a broad range of patients. With this FDA clearance, we eagerly anticipate making a substantial impact across the value chain."
The MARS platform is designed for use in both hospitals and ambulatory surgery centers.